"Virus Replication" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
| Descriptor ID |
D014779
|
| MeSH Number(s) |
G06.920.925
|
| Concept/Terms |
Virus Replication- Virus Replication
- Replication, Virus
- Replications, Virus
- Virus Replications
|
Below are MeSH descriptors whose meaning is more general than "Virus Replication".
Below are MeSH descriptors whose meaning is more specific than "Virus Replication".
This graph shows the total number of publications written about "Virus Replication" by people in this website by year, and whether "Virus Replication" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 6 | 7 |
| 2004 | 2 | 3 | 5 |
| 2005 | 4 | 5 | 9 |
| 2006 | 4 | 8 | 12 |
| 2007 | 4 | 3 | 7 |
| 2008 | 1 | 5 | 6 |
| 2009 | 2 | 4 | 6 |
| 2010 | 4 | 2 | 6 |
| 2011 | 2 | 5 | 7 |
| 2012 | 6 | 7 | 13 |
| 2013 | 4 | 5 | 9 |
| 2014 | 8 | 4 | 12 |
| 2015 | 3 | 3 | 6 |
| 2016 | 7 | 6 | 13 |
| 2017 | 2 | 4 | 6 |
| 2018 | 6 | 4 | 10 |
| 2019 | 2 | 6 | 8 |
| 2020 | 2 | 2 | 4 |
| 2021 | 3 | 3 | 6 |
| 2022 | 0 | 2 | 2 |
| 2023 | 1 | 5 | 6 |
| 2024 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Virus Replication" by people in Profiles.
-
Obregon-Perko V, Mannino A, Ladner JT, Hodara V, Ebrahimi D, Parodi L, Callery J, Palacios G, Giavedoni LD. Adaptation of SIVmac to baboon primary cells results in complete absence of in vivo baboon infectivity. Front Cell Infect Microbiol. 2024; 14:1408245.
-
Holmes J, Islam SM, Milligan KA. Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations. Viruses. 2024 May 30; 16(6).
-
Martin J, Chen X, Jia X, Shao Q, Liu B. The Disassociation of A3G-Related HIV-1 cDNA G-to-A Hypermutation to Viral Infectivity. Viruses. 2024 05 04; 16(5).
-
Bracci N, Baer A, Flor R, Petraccione K, Stocker T, Zhou W, Ammosova T, Dinglasan RR, Nekhai S, Kehn-Hall K. CK1 and PP1 regulate Rift Valley fever virus genome replication through L protein phosphorylation. Antiviral Res. 2024 Jun; 226:105895.
-
Valenzuela C, Saucedo S, Llano M. Schlafen14 Impairs HIV-1 Expression in a Codon Usage-Dependent Manner. Viruses. 2024 03 25; 16(4).
-
Yang R, Pan M, Guo J, Huang Y, Zhang QC, Deng T, Wang J. Mapping of the influenza A virus genome RNA structure and interactions reveals essential elements of viral replication. Cell Rep. 2024 Mar 26; 43(3):113833.
-
Silva BJA, Krogstad PA, Teles RMB, Andrade PR, Rajfer J, Ferrini MG, Yang OO, Bloom BR, Modlin RL. IFN-?-mediated control of SARS-CoV-2 infection through nitric oxide. Front Immunol. 2023; 14:1284148.
-
Dwivedi R, Prakash P, Kumbhar BV, Balasubramaniam M, Dash C. HIV-1 capsid and viral DNA integration. mBio. 2024 Jan 16; 15(1):e0021222.
-
Calhoun JC, Damania B, Griffith JD, Costantini LM. Electron microscopy mapping of the DNA-binding sites of monomeric, dimeric, and multimeric KSHV RTA protein. J Virol. 2023 10 31; 97(10):e0063723.
-
Du L, Bouzidi MS, Gala A, Deiter F, Billaud JN, Yeung ST, Dabral P, Jin J, Simmons G, Dossani ZY, Niki T, Ndhlovu LC, Greenland JR, Pillai SK. Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells. J Mol Cell Biol. 2023 08 03; 15(4).